

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | high-density lipoprotein particle remodeling (GO:0034375) | 5.90875059 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 5.37189960 |
| 3 | reverse cholesterol transport (GO:0043691) | 5.29147979 |
| 4 | regulation of triglyceride catabolic process (GO:0010896) | 4.96651845 |
| 5 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.84792154 |
| 6 | carnitine shuttle (GO:0006853) | 4.77901553 |
| 7 | phospholipid efflux (GO:0033700) | 4.68782393 |
| 8 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.62648174 |
| 9 | response to inactivity (GO:0014854) | 4.42522146 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.37619464 |
| 11 | sphingomyelin metabolic process (GO:0006684) | 4.26257021 |
| 12 | amino-acid betaine transport (GO:0015838) | 4.25600463 |
| 13 | carnitine transport (GO:0015879) | 4.25600463 |
| 14 | protein-lipid complex remodeling (GO:0034368) | 4.22536461 |
| 15 | macromolecular complex remodeling (GO:0034367) | 4.22536461 |
| 16 | plasma lipoprotein particle remodeling (GO:0034369) | 4.22536461 |
| 17 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.20857284 |
| 18 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.20839061 |
| 19 | regulation of energy homeostasis (GO:2000505) | 4.15022826 |
| 20 | cholesterol efflux (GO:0033344) | 4.14450453 |
| 21 | fatty acid transmembrane transport (GO:1902001) | 4.13728027 |
| 22 | carnitine transmembrane transport (GO:1902603) | 4.10509335 |
| 23 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.94721920 |
| 24 | positive regulation of glycolytic process (GO:0045821) | 3.77990341 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 3.68994461 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 3.66770086 |
| 27 | skeletal muscle adaptation (GO:0043501) | 3.60271833 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.56097543 |
| 29 | epithelial cilium movement (GO:0003351) | 3.53306318 |
| 30 | plasma lipoprotein particle assembly (GO:0034377) | 3.49626449 |
| 31 | NLS-bearing protein import into nucleus (GO:0006607) | 3.45946446 |
| 32 | mitotic sister chromatid cohesion (GO:0007064) | 3.43634124 |
| 33 | keratinocyte development (GO:0003334) | 3.42274755 |
| 34 | cellular response to ethanol (GO:0071361) | 3.41396695 |
| 35 | interkinetic nuclear migration (GO:0022027) | 3.39999047 |
| 36 | growth hormone receptor signaling pathway (GO:0060396) | 3.39911291 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 3.37634083 |
| 38 | intracellular lipid transport (GO:0032365) | 3.36298867 |
| 39 | establishment of protein localization to Golgi (GO:0072600) | 3.35444879 |
| 40 | protein-lipid complex assembly (GO:0065005) | 3.31262979 |
| 41 | COPII vesicle coating (GO:0048208) | 3.31116194 |
| 42 | quaternary ammonium group transport (GO:0015697) | 3.29043691 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 3.27239543 |
| 44 | cytoplasmic microtubule organization (GO:0031122) | 3.26813314 |
| 45 | protein targeting to Golgi (GO:0000042) | 3.23290474 |
| 46 | macroautophagy (GO:0016236) | 3.22170843 |
| 47 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.21842167 |
| 48 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.21830682 |
| 49 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.21830682 |
| 50 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.21830682 |
| 51 | lactate metabolic process (GO:0006089) | 3.21577881 |
| 52 | cilium movement (GO:0003341) | 3.17480533 |
| 53 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.16626873 |
| 54 | regulation of female receptivity (GO:0045924) | 3.16248225 |
| 55 | vesicle transport along microtubule (GO:0047496) | 3.12840152 |
| 56 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.12371706 |
| 57 | neural tube formation (GO:0001841) | 3.11798376 |
| 58 | plasma lipoprotein particle organization (GO:0071827) | 3.11711765 |
| 59 | muscle atrophy (GO:0014889) | 3.11416589 |
| 60 | cellular response to growth hormone stimulus (GO:0071378) | 3.11290028 |
| 61 | regulation of protein glycosylation (GO:0060049) | 3.10025076 |
| 62 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.08231267 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.07013368 |
| 64 | cAMP catabolic process (GO:0006198) | 3.05482713 |
| 65 | nucleus localization (GO:0051647) | 3.04687272 |
| 66 | protein-lipid complex subunit organization (GO:0071825) | 3.03993186 |
| 67 | regulation of DNA endoreduplication (GO:0032875) | 3.02067984 |
| 68 | succinate metabolic process (GO:0006105) | 3.01574807 |
| 69 | tyrosine metabolic process (GO:0006570) | 2.99950475 |
| 70 | neuronal action potential propagation (GO:0019227) | 2.98649554 |
| 71 | lipoprotein transport (GO:0042953) | 2.96479331 |
| 72 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95674178 |
| 73 | ketone body metabolic process (GO:1902224) | 2.91250841 |
| 74 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.89239500 |
| 75 | regulation of digestive system process (GO:0044058) | 2.85668463 |
| 76 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.82438130 |
| 77 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.82292554 |
| 78 | coenzyme catabolic process (GO:0009109) | 2.81765711 |
| 79 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.79063130 |
| 80 | triglyceride homeostasis (GO:0070328) | 2.78636459 |
| 81 | acylglycerol homeostasis (GO:0055090) | 2.78636459 |
| 82 | striated muscle atrophy (GO:0014891) | 2.75369795 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 2.74253671 |
| 84 | drug catabolic process (GO:0042737) | 2.73436546 |
| 85 | negative regulation of complement activation (GO:0045916) | 2.72466107 |
| 86 | opioid receptor signaling pathway (GO:0038003) | 2.70454753 |
| 87 | cyclic nucleotide catabolic process (GO:0009214) | 2.69955583 |
| 88 | prostate gland growth (GO:0060736) | 2.69712344 |
| 89 | developmental pigmentation (GO:0048066) | 2.68403873 |
| 90 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.67889799 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 2.67883056 |
| 92 | muscle filament sliding (GO:0030049) | 2.65197840 |
| 93 | actin-myosin filament sliding (GO:0033275) | 2.65197840 |
| 94 | negative regulation of sterol transport (GO:0032372) | 2.64838490 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 2.64838490 |
| 96 | hepatocyte differentiation (GO:0070365) | 2.64673902 |
| 97 | actin-mediated cell contraction (GO:0070252) | 2.62813282 |
| 98 | regulation of glucokinase activity (GO:0033131) | 2.57514702 |
| 99 | regulation of hexokinase activity (GO:1903299) | 2.57514702 |
| 100 | genitalia morphogenesis (GO:0035112) | 2.57106412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.86654423 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.10949500 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.86839976 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.76521291 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.71225867 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58667204 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.39900729 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38965271 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.30146159 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15434339 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12617913 |
| 12 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.11287381 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09666298 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.04535392 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03281890 |
| 16 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.97252092 |
| 17 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.86314222 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85141522 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.84105427 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83961664 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82390454 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81793357 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74853370 |
| 24 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.74070218 |
| 25 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.68979781 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68294879 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68021755 |
| 28 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.65954853 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.65954853 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.65636659 |
| 31 | TCF4_23295773_ChIP-Seq_U87_Human | 1.65604198 |
| 32 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.64196661 |
| 33 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.62609439 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61643302 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.61269964 |
| 36 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.57709784 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.57540151 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56552312 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56542199 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54359681 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53225723 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48157164 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47481193 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45376791 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44319059 |
| 46 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.43984970 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43178815 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42910820 |
| 49 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.42290063 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39078592 |
| 51 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.38957670 |
| 52 | RXR_22108803_ChIP-Seq_LS180_Human | 1.37337881 |
| 53 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36620552 |
| 54 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36522344 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35896348 |
| 56 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.35713432 |
| 57 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34923500 |
| 58 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.34256579 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33860062 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32568202 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32321416 |
| 62 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.31112819 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30373801 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30373801 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29846671 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28954690 |
| 67 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28647010 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26501904 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25588115 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24847586 |
| 71 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.24762828 |
| 72 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.24029970 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23933237 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23933237 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23627461 |
| 76 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21499147 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19713325 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19569849 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19333451 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17169525 |
| 81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16326917 |
| 82 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.12559766 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12368527 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12179468 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12058767 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11044866 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10131610 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10068248 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09837416 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.09437564 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09342976 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09179535 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09139479 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08459448 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08459448 |
| 96 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07407769 |
| 97 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.07192829 |
| 98 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07089787 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07010144 |
| 100 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05890467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005645_abnormal_hypothalamus_physiol | 4.55688997 |
| 2 | MP0000372_irregular_coat_pigmentation | 3.55388469 |
| 3 | MP0003646_muscle_fatigue | 3.34854899 |
| 4 | MP0009840_abnormal_foam_cell | 3.24317302 |
| 5 | MP0004381_abnormal_hair_follicle | 3.18244080 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.12161817 |
| 7 | MP0003136_yellow_coat_color | 3.08368422 |
| 8 | MP0000751_myopathy | 3.00678431 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.96638867 |
| 10 | MP0004270_analgesia | 2.91036038 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.65142714 |
| 12 | MP0000749_muscle_degeneration | 2.64771782 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.30963473 |
| 14 | MP0003195_calcinosis | 2.22397538 |
| 15 | MP0004130_abnormal_muscle_cell | 2.05441018 |
| 16 | MP0003045_fibrosis | 1.99739548 |
| 17 | MP0004510_myositis | 1.97004748 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.93093788 |
| 19 | MP0002928_abnormal_bile_duct | 1.86512277 |
| 20 | MP0000003_abnormal_adipose_tissue | 1.86165836 |
| 21 | MP0004233_abnormal_muscle_weight | 1.80369210 |
| 22 | MP0003868_abnormal_feces_composition | 1.74721003 |
| 23 | MP0003252_abnormal_bile_duct | 1.73972411 |
| 24 | MP0005360_urolithiasis | 1.73946062 |
| 25 | MP0005171_absent_coat_pigmentation | 1.71851427 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.70061854 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.67153785 |
| 28 | MP0003787_abnormal_imprinting | 1.61358719 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.58613403 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.52524420 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.51933034 |
| 32 | MP0001502_abnormal_circadian_rhythm | 1.49841223 |
| 33 | MP0002269_muscular_atrophy | 1.48396019 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.47019331 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.46184516 |
| 36 | MP0000747_muscle_weakness | 1.44949636 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.44838097 |
| 38 | MP0000371_diluted_coat_color | 1.41728306 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.41358183 |
| 40 | MP0005408_hypopigmentation | 1.37013104 |
| 41 | MP0005330_cardiomyopathy | 1.31120332 |
| 42 | MP0005310_abnormal_salivary_gland | 1.30234867 |
| 43 | MP0001661_extended_life_span | 1.29249371 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.28376728 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.28374704 |
| 46 | MP0005369_muscle_phenotype | 1.26719695 |
| 47 | MP0000427_abnormal_hair_cycle | 1.25985160 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.24856477 |
| 49 | MP0005365_abnormal_bile_salt | 1.24452604 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.19935550 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.18382609 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.17350201 |
| 53 | MP0001984_abnormal_olfaction | 1.13310012 |
| 54 | MP0002971_abnormal_brown_adipose | 1.11075855 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.10272875 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.10035016 |
| 57 | MP0002168_other_aberrant_phenotype | 1.09800922 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.09740037 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.08510465 |
| 60 | MP0004142_abnormal_muscle_tone | 1.08401546 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.07913297 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.06818033 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.04034885 |
| 64 | MP0005332_abnormal_amino_acid | 1.02920664 |
| 65 | MP0003123_paternal_imprinting | 1.01454895 |
| 66 | MP0008877_abnormal_DNA_methylation | 0.98288347 |
| 67 | MP0005253_abnormal_eye_physiology | 0.98271601 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98109820 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.98068415 |
| 70 | MP0002163_abnormal_gland_morphology | 0.97031011 |
| 71 | MP0005535_abnormal_body_temperature | 0.96312538 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 0.94877985 |
| 73 | MP0005670_abnormal_white_adipose | 0.92061759 |
| 74 | MP0002822_catalepsy | 0.90967207 |
| 75 | MP0002108_abnormal_muscle_morphology | 0.89265509 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 0.88203386 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.87859213 |
| 78 | MP0003879_abnormal_hair_cell | 0.86563844 |
| 79 | MP0005620_abnormal_muscle_contractility | 0.86024555 |
| 80 | MP0003122_maternal_imprinting | 0.85574670 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.84248710 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.83376393 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.82104309 |
| 84 | MP0002127_abnormal_cardiovascular_syste | 0.81033632 |
| 85 | MP0002009_preneoplasia | 0.80105048 |
| 86 | MP0005334_abnormal_fat_pad | 0.77909221 |
| 87 | MP0000733_abnormal_muscle_development | 0.77661018 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.77387395 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.76571592 |
| 90 | MP0005451_abnormal_body_composition | 0.75387962 |
| 91 | MP0003121_genomic_imprinting | 0.70274116 |
| 92 | MP0001764_abnormal_homeostasis | 0.70077534 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.70000732 |
| 94 | MP0009046_muscle_twitch | 0.69455538 |
| 95 | MP0003866_abnormal_defecation | 0.69283909 |
| 96 | MP0002938_white_spotting | 0.67963191 |
| 97 | MP0005248_abnormal_Harderian_gland | 0.67350175 |
| 98 | MP0002557_abnormal_social/conspecific_i | 0.67253100 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.66987005 |
| 100 | MP0005266_abnormal_metabolism | 0.66911565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 6.68911105 |
| 2 | Nemaline bodies (HP:0003798) | 6.47452737 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.74712368 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 5.54493676 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.34666233 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.55467905 |
| 7 | Hepatoblastoma (HP:0002884) | 4.30922011 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 4.10464706 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 3.98866642 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.89353627 |
| 11 | Hyperkalemia (HP:0002153) | 3.63621425 |
| 12 | Septo-optic dysplasia (HP:0100842) | 3.57129521 |
| 13 | Difficulty running (HP:0009046) | 3.45759540 |
| 14 | Long clavicles (HP:0000890) | 3.43757813 |
| 15 | Albinism (HP:0001022) | 3.38526714 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.34257234 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.19026659 |
| 18 | Fetal akinesia sequence (HP:0001989) | 3.17763837 |
| 19 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.12920405 |
| 20 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.12920405 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 3.10136619 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.07483035 |
| 23 | Malignant hyperthermia (HP:0002047) | 3.00038260 |
| 24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.95719517 |
| 25 | Hypolipoproteinemia (HP:0010981) | 2.92788426 |
| 26 | Decreased lacrimation (HP:0000633) | 2.91935607 |
| 27 | Blue irides (HP:0000635) | 2.90784042 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.76364135 |
| 29 | Epidermoid cyst (HP:0200040) | 2.75869647 |
| 30 | Rimmed vacuoles (HP:0003805) | 2.75098420 |
| 31 | Large for gestational age (HP:0001520) | 2.68781875 |
| 32 | Maternal diabetes (HP:0009800) | 2.68109470 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 2.68046675 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.61966670 |
| 35 | Fair hair (HP:0002286) | 2.61338640 |
| 36 | Thyroid carcinoma (HP:0002890) | 2.58046131 |
| 37 | Nonprogressive disorder (HP:0003680) | 2.55337533 |
| 38 | Pelvic girdle muscle weakness (HP:0003749) | 2.50512806 |
| 39 | Myopathic facies (HP:0002058) | 2.48046147 |
| 40 | Abnormality of the neuromuscular junction (HP:0003398) | 2.45403684 |
| 41 | Fatigable weakness (HP:0003473) | 2.45403684 |
| 42 | Hypoplastic iliac wings (HP:0002866) | 2.41567058 |
| 43 | Akinesia (HP:0002304) | 2.37609040 |
| 44 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36181065 |
| 45 | Generalized hypopigmentation of hair (HP:0011358) | 2.33655695 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.30741656 |
| 47 | Neck muscle weakness (HP:0000467) | 2.30251365 |
| 48 | Hypomagnesemia (HP:0002917) | 2.27952465 |
| 49 | Pheochromocytoma (HP:0002666) | 2.26913146 |
| 50 | Myoglobinuria (HP:0002913) | 2.25837060 |
| 51 | Anosmia (HP:0000458) | 2.25602374 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25591927 |
| 53 | Anhidrosis (HP:0000970) | 2.23010012 |
| 54 | White forelock (HP:0002211) | 2.22094847 |
| 55 | Truncal obesity (HP:0001956) | 2.21912601 |
| 56 | Patchy hypopigmentation of hair (HP:0011365) | 2.21589281 |
| 57 | Neoplasm of the adrenal gland (HP:0100631) | 2.20942487 |
| 58 | Intestinal atresia (HP:0011100) | 2.19964949 |
| 59 | Volvulus (HP:0002580) | 2.18037668 |
| 60 | Frequent falls (HP:0002359) | 2.16527222 |
| 61 | Shoulder girdle muscle weakness (HP:0003547) | 2.13326169 |
| 62 | Muscular dystrophy (HP:0003560) | 2.09179060 |
| 63 | Ketoacidosis (HP:0001993) | 2.04709455 |
| 64 | Neoplasm of the adrenal cortex (HP:0100641) | 2.03087077 |
| 65 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.01679226 |
| 66 | Subaortic stenosis (HP:0001682) | 2.01679226 |
| 67 | Tetany (HP:0001281) | 1.99066053 |
| 68 | Generalized muscle weakness (HP:0003324) | 1.98990125 |
| 69 | Optic nerve hypoplasia (HP:0000609) | 1.98826139 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 1.97476653 |
| 71 | Hamartoma of the eye (HP:0010568) | 1.96463156 |
| 72 | Hyperphosphatemia (HP:0002905) | 1.95480985 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 1.93750053 |
| 74 | Abnormality of potassium homeostasis (HP:0011042) | 1.93063309 |
| 75 | Abnormality of chloride homeostasis (HP:0011422) | 1.88922614 |
| 76 | Popliteal pterygium (HP:0009756) | 1.88283595 |
| 77 | Alacrima (HP:0000522) | 1.87994409 |
| 78 | Abnormal pancreas size (HP:0012094) | 1.84906060 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.83388156 |
| 80 | Truncal ataxia (HP:0002078) | 1.82929315 |
| 81 | Hyperventilation (HP:0002883) | 1.81433853 |
| 82 | Increased density of long bones (HP:0006392) | 1.80710100 |
| 83 | Generalized hypopigmentation (HP:0007513) | 1.79709637 |
| 84 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79647800 |
| 85 | Increased connective tissue (HP:0009025) | 1.77279715 |
| 86 | Distal arthrogryposis (HP:0005684) | 1.76894456 |
| 87 | Hyporeflexia of lower limbs (HP:0002600) | 1.76167652 |
| 88 | Gowers sign (HP:0003391) | 1.75689602 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.74875995 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74212628 |
| 91 | Ketosis (HP:0001946) | 1.73640040 |
| 92 | Bronchiectasis (HP:0002110) | 1.72229193 |
| 93 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.71984562 |
| 94 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.71984562 |
| 95 | Delayed puberty (HP:0000823) | 1.70913367 |
| 96 | Thyroiditis (HP:0100646) | 1.70079488 |
| 97 | Rhinitis (HP:0012384) | 1.69694912 |
| 98 | Absent septum pellucidum (HP:0001331) | 1.68644647 |
| 99 | Hypoplasia of the iris (HP:0007676) | 1.67624695 |
| 100 | Severe visual impairment (HP:0001141) | 1.67025755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.68435158 |
| 2 | FRK | 4.92226716 |
| 3 | PIK3CG | 3.72573156 |
| 4 | WNK3 | 3.36154988 |
| 5 | ACVR1B | 3.35669253 |
| 6 | MUSK | 3.19053119 |
| 7 | MAP3K7 | 2.86515810 |
| 8 | FGFR2 | 2.83762448 |
| 9 | EPHA3 | 2.68375310 |
| 10 | ADRBK2 | 2.63183820 |
| 11 | NLK | 2.59037654 |
| 12 | TNIK | 2.37806380 |
| 13 | BRD4 | 2.31532442 |
| 14 | FGFR3 | 2.20073144 |
| 15 | PRKD3 | 2.10074441 |
| 16 | PINK1 | 1.99099296 |
| 17 | PHKG2 | 1.61804901 |
| 18 | PHKG1 | 1.61804901 |
| 19 | NEK6 | 1.58148402 |
| 20 | MAP3K10 | 1.56257150 |
| 21 | MARK3 | 1.49996027 |
| 22 | BRSK2 | 1.40575185 |
| 23 | SGK2 | 1.38134957 |
| 24 | PRKAA2 | 1.38025365 |
| 25 | MAP3K2 | 1.28593798 |
| 26 | MAP3K4 | 1.24896944 |
| 27 | FGFR4 | 1.23835767 |
| 28 | FER | 1.19732804 |
| 29 | PTK2B | 1.11534783 |
| 30 | JAK1 | 1.01416469 |
| 31 | STK39 | 0.99550061 |
| 32 | PASK | 0.96237896 |
| 33 | SGK3 | 0.94696628 |
| 34 | SGK223 | 0.91552850 |
| 35 | SGK494 | 0.91552850 |
| 36 | CAMKK2 | 0.91345024 |
| 37 | MST4 | 0.87197648 |
| 38 | BCR | 0.80405228 |
| 39 | MARK2 | 0.80169047 |
| 40 | ERBB3 | 0.79587634 |
| 41 | HIPK2 | 0.79110017 |
| 42 | DAPK2 | 0.75676495 |
| 43 | SCYL2 | 0.73517891 |
| 44 | STK38L | 0.68064809 |
| 45 | EIF2AK3 | 0.66127930 |
| 46 | PRKAA1 | 0.63711332 |
| 47 | WNK1 | 0.62823892 |
| 48 | MELK | 0.60769957 |
| 49 | EPHB1 | 0.59732960 |
| 50 | CAMK4 | 0.58425298 |
| 51 | PAK3 | 0.57435776 |
| 52 | NME1 | 0.55991019 |
| 53 | STK11 | 0.53613206 |
| 54 | MAPK11 | 0.52552621 |
| 55 | CDK12 | 0.52474327 |
| 56 | MAP2K6 | 0.52335606 |
| 57 | SGK1 | 0.51050839 |
| 58 | IRAK2 | 0.49025468 |
| 59 | OXSR1 | 0.48872784 |
| 60 | PIK3CA | 0.48657064 |
| 61 | STK38 | 0.47636545 |
| 62 | PLK4 | 0.46529829 |
| 63 | MAP3K14 | 0.46010078 |
| 64 | PDK2 | 0.45820095 |
| 65 | RET | 0.45443846 |
| 66 | NEK9 | 0.45180365 |
| 67 | FGFR1 | 0.45143841 |
| 68 | JAK2 | 0.44776907 |
| 69 | RPS6KB1 | 0.43304753 |
| 70 | MAP4K1 | 0.42813308 |
| 71 | ITK | 0.41553645 |
| 72 | TRPM7 | 0.41234304 |
| 73 | MAPK13 | 0.40484752 |
| 74 | NTRK3 | 0.39784695 |
| 75 | TXK | 0.39366792 |
| 76 | CCNB1 | 0.37725255 |
| 77 | PRKCZ | 0.37340997 |
| 78 | TAOK3 | 0.36851627 |
| 79 | INSRR | 0.36219692 |
| 80 | YES1 | 0.34301947 |
| 81 | MAP4K2 | 0.33366525 |
| 82 | IRAK1 | 0.32557408 |
| 83 | PRKCH | 0.31620547 |
| 84 | CDK8 | 0.27299873 |
| 85 | RPS6KA3 | 0.27125990 |
| 86 | PRKG1 | 0.26505995 |
| 87 | CDC42BPA | 0.26329389 |
| 88 | PRKCI | 0.26135584 |
| 89 | CSNK1A1L | 0.25014002 |
| 90 | TTN | 0.24812148 |
| 91 | TYK2 | 0.24045747 |
| 92 | MAP2K1 | 0.23900497 |
| 93 | WNK4 | 0.23812570 |
| 94 | PRKCQ | 0.23692144 |
| 95 | PKN1 | 0.22738582 |
| 96 | PRKACB | 0.22697631 |
| 97 | MARK1 | 0.21888915 |
| 98 | UHMK1 | 0.21003721 |
| 99 | MINK1 | 0.20571362 |
| 100 | MAPK7 | 0.18902992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Circadian rhythm_Homo sapiens_hsa04710 | 3.93782172 |
| 2 | ABC transporters_Homo sapiens_hsa02010 | 3.42587426 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.81926074 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.74894055 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.52818687 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.37502625 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.33182838 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24471064 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89526860 |
| 10 | Insulin resistance_Homo sapiens_hsa04931 | 1.78346763 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76086967 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73018785 |
| 13 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.72274022 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.70768260 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64022183 |
| 16 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.62667647 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60183355 |
| 18 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.54965263 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53077820 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.50597685 |
| 21 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.44129163 |
| 22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.42225489 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41749546 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.40804248 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.34420069 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.34338047 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33042818 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.31753009 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24095059 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22967895 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.22876680 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22857369 |
| 33 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.19903689 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19095149 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18381303 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.11934559 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01651074 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00817462 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99938663 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99064902 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92863444 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89299546 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 0.87236305 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86685716 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86210078 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85321685 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82054264 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80057193 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79652770 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77873605 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76902977 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76426757 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74623061 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73696585 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72155299 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 0.70860954 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69928569 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69168073 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68125158 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67775871 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67106266 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66999035 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.65328048 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.64275114 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60501471 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59578628 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58141173 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.57725684 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56956621 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53753511 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53635748 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51657761 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.50986181 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.50304223 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50265422 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50148604 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48074590 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47349702 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.44341156 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.42755013 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40947005 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37723072 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37692015 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37391192 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36774827 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36164400 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35843394 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35666754 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.35599227 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35522642 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.34897120 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33763894 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33293507 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32891512 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31232995 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30991282 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30895383 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.30664591 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30597276 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30373415 |

